Related Experiment Video
Updated: Feb 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1
Zhenchong Xiong1, Liping Ye2, He Zhenyu3
1Department of Breast Surgery, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Abstract:
Triple-negative breast cancer (TNBC) lacks expression of estrogen receptor (ER), progesterone receptor, and the HER2 receptor; it is highly proliferative and becomes the deadliest forms of breast cancer. Effective prognostic methods and therapeutic targets for TNBC are required to improve patient outcomes. Here, we report that acidic nuclear phosphoprotein 32 family member E (ANP32E), which promotes cell proliferation in mammalian development, is highly expressed in TNBC cells compared to other types of breast cancer. High expression of ANP32E correlates significantly with worse overall survival (OS; P < 0.001) and higher risks of disease recurrence (P < 0.001) in patients with TNBC. Univariate and multivariate Cox-regression models show that ANP32E is an independent prognostic factor in TNBC. Furthermore, we discovered that ANP32E promotes tumor proliferation in vitro by inducing G1/S transition, and ANP32E inhibition suppresses tumor formation in vivo. By examining the expression of E2F1, cyclin E1, and cyclin E2, we discovered that ANP32E promotes the G1/S transition by transcriptionally inducing E2F1. Taken together, our study shows that ANP32E is an efficient prognostic marker, and it promotes the G1/S transition and induces tumorigenesis of TNBC cells by transcriptionally inducing E2F1.
Insights
Acidic nuclear phosphoprotein 32 family member E (ANP32E) is highly expressed in triple-negative breast cancer (TNBC). High ANP32E levels indicate poor prognosis and promote TNBC cell proliferation by inducing cell cycle transition.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) is aggressive and lacks targeted therapies.
- Effective prognostic markers and therapeutic targets are crucial for improving TNBC patient outcomes.
Purpose of the Study:
- To investigate the role of acidic nuclear phosphoprotein 32 family member E (ANP32E) in TNBC.
- To determine if ANP32E can serve as a prognostic marker and therapeutic target for TNBC.
Main Methods:
- Compared ANP32E expression in TNBC versus other breast cancers.
- Correlated ANP32E expression with patient survival and recurrence using Cox-regression models.
- Assessed ANP32E's effect on TNBC cell proliferation in vitro and tumor formation in vivo.
- Investigated ANP32E's mechanism involving E2F1, cyclin E1, and cyclin E2.
Main Results:
- ANP32E is significantly overexpressed in TNBC.
- High ANP32E expression correlates with worse overall survival and increased recurrence risk in TNBC patients.
- ANP32E promotes TNBC proliferation by inducing G1/S cell cycle transition via transcriptional induction of E2F1.
- ANP32E inhibition suppressed tumor formation in vivo.
Conclusions:
- ANP32E is an independent prognostic factor for TNBC.
- ANP32E promotes TNBC tumorigenesis by regulating the G1/S transition through E2F1.
- ANP32E represents a potential therapeutic target and prognostic marker for TNBC.
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Negative Regulator Molecules
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Positive, Negative, and Zero Work
Induced Pluripotent Stem Cells
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...

